New York, NYCIK 12249625 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
111 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Praxis Precision Medicines I | 2.00M | $588.30M | 10.8% | +431.4K | Added |
| 2 | Celcuity Inc | 3.16M | $315.20M | 5.8% | +203.9K | Added |
| 3 | Rhythm Pharmaceuticals Inc | 2.55M | $272.57M | 5.0% | +107.4K | Added |
| 4 | Ascendis Pharma A/S |
| 1.08M |
| $230.60M |
| 4.2% |
| −7.1K |
| Reduced |
| 5 | Apogee Therapeutics Inc | 2.33M | $175.92M | 3.2% | +978.7K | Added |
| 6 | Roivant Sciences Ltd | 7.99M | $173.28M | 3.2% | +617.0K | Added |
| 7 | Nuvalent Inc | 1.67M | $167.49M | 3.1% | +102.8K | Added |
| 8 | Travere Therapeutics Inc | 4.28M | $163.47M | 3.0% | +483.6K | Added |
| 9 | Exact Sciences Corp | 1.20M | $121.92M | 2.2% | +735.0K | Added |
| 10 | Protagonist Therapeutics Inc | 1.35M | $117.95M | 2.2% | +320.3K | Added |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio